HI Fundamental Analysis - HEALTH ITALIA SPA

Fundamental Rating

We assign a fundamental rating of 5 out of 10 to HI. HI was compared to 27 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making HI a very profitable company, without any liquidiy or solvency issues. HI has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

HI had positive earnings in the past year.

HI had a positive operating cash flow in the past year.

In the past 5 years HI has always been profitable.

Each year in the past 5 years HI had a positive operating cash flow.

1.2 Ratios

HI's Return On Assets of 4.16% is fine compared to the rest of the industry. HI outperforms 74.07% of its industry peers.

HI's Return On Equity of 6.91% is in line compared to the rest of the industry. HI outperforms 51.85% of its industry peers.

HI has a Return On Invested Capital of 5.21%. This is comparable to the rest of the industry: HI outperforms 59.26% of its industry peers.

HI had an Average Return On Invested Capital over the past 3 years of 7.13%. This is in line with the industry average of 6.10%.

		Industry Rank	Sector Rank
ROA	4.16%
ROE	6.91%
ROIC	5.21%

ROA(3y)3.96%

ROA(5y)3.25%

ROE(3y)7.81%

ROE(5y)6.83%

ROIC(3y)7.13%

ROIC(5y)6%

1.3 Margins

HI has a better Profit Margin (7.52%) than 92.59% of its industry peers.

In the last couple of years the Profit Margin of HI has grown nicely.

The Operating Margin of HI (12.85%) is better than 96.30% of its industry peers.

HI's Operating Margin has improved in the last couple of years.

The Gross Margin of HI (33.27%) is comparable to the rest of the industry.

In the last couple of years the Gross Margin of HI has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	12.85%
PM (TTM)	7.52%
GM	33.27%

OM growth 3Y8%

OM growth 5YN/A

PM growth 3Y33.22%

PM growth 5Y9.47%

GM growth 3Y-1.7%

GM growth 5Y-0.8%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

Compared to 1 year ago, HI has more shares outstanding

HI has less shares outstanding than it did 5 years ago.

HI has a better debt/assets ratio than last year.

2.2 Solvency

HI has an Altman-Z score of 3.02. This indicates that HI is financially healthy and has little risk of bankruptcy at the moment.

With an excellent Altman-Z score value of 3.02, HI belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.

HI has a debt to FCF ratio of 15.21. This is a negative value and a sign of low solvency as HI would need 15.21 years to pay back of all of its debts.

HI has a Debt to FCF ratio of 15.21. This is in the lower half of the industry: HI underperforms 70.37% of its industry peers.

A Debt/Equity ratio of 0.22 indicates that HI is not too dependend on debt financing.

HI's Debt to Equity ratio of 0.22 is amongst the best of the industry. HI outperforms 88.89% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	15.21
Altman-Z	3.02

ROIC/WACC0.71

WACC7.33%

2.3 Liquidity

A Current Ratio of 3.18 indicates that HI has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 3.18, HI belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.

HI has a Quick Ratio of 3.18. This indicates that HI is financially healthy and has no problem in meeting its short term obligations.

HI's Quick ratio of 3.18 is amongst the best of the industry. HI outperforms 96.30% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.18
Quick Ratio	3.18

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.15%, which is quite impressive.

The Earnings Per Share has been growing by 181.50% on average over the past years. This is a very strong growth

HI shows a decrease in Revenue. In the last year, the revenue decreased by -0.86%.

The Revenue has been growing slightly by 2.37% on average over the past years.

EPS 1Y (TTM)61.15%

EPS 3Y27.76%

EPS 5Y181.5%

EPS Q2Q%504.86%

Revenue 1Y (TTM)-0.86%

Revenue growth 3Y-3.68%

Revenue growth 5Y2.37%

Sales Q2Q%-10.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.04, HI is valued on the expensive side.

The rest of the industry has a similar Price/Earnings ratio as HI.

When comparing the Price/Earnings ratio of HI to the average of the S&P500 Index (27.02), we can say HI is valued slightly cheaper.

		Industry Rank	Sector Rank
PE	20.04
Fwd PE	N/A

4.2 Price Multiples

HI's Enterprise Value to EBITDA ratio is in line with the industry average.

HI's Price/Free Cash Flow ratio is rather expensive when compared to the industry. HI is more expensive than 81.48% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	88.76
EV/EBITDA	9.83

4.3 Compensation for Growth

The decent profitability rating of HI may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.11

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEALTH ITALIA SPA

BIT:HI (9/8/2025, 7:00:00 PM)

281

+1 (+0.36%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap53.39M

Analysts84.44

Price Target372.3 (32.49%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	20.04
Fwd PE	N/A
P/S	1.51
P/FCF	88.76
P/OCF	17.44
P/B	1.39
P/tB	1.52
EV/EBITDA	9.83

EPS(TTM)14.02

EY4.99%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)3.17

FCFY1.13%

OCF(TTM)16.11

OCFY5.73%

SpS186.12

BVpS202.44

TBVpS184.42

PEG (NY)N/A

PEG (5Y)0.11

Profitability

		Industry Rank	Sector Rank
ROA	4.16%
ROE	6.91%
ROCE	9.35%
ROIC	5.21%
ROICexc	5.54%
ROICexgc	5.97%
OM	12.85%
PM (TTM)	7.52%
GM	33.27%
FCFM	1.7%

ROA(3y)3.96%

ROA(5y)3.25%

ROE(3y)7.81%

ROE(5y)6.83%

ROIC(3y)7.13%

ROIC(5y)6%

ROICexc(3y)7.88%

ROICexc(5y)6.76%

ROICexgc(3y)8.74%

ROICexgc(5y)7.6%

ROCE(3y)12.74%

ROCE(5y)10.6%

ROICexcg growth 3Y-3.65%

ROICexcg growth 5YN/A

ROICexc growth 3Y-1.37%

ROICexc growth 5YN/A

OM growth 3Y8%

OM growth 5YN/A

PM growth 3Y33.22%

PM growth 5Y9.47%

GM growth 3Y-1.7%

GM growth 5Y-0.8%

F-Score7

Asset Turnover0.55

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	15.21
Debt/EBITDA	1.49
Cap/Depr	221.98%
Cap/Sales	6.96%
Interest Coverage	250
Cash Conversion	54.18%
Profit Quality	22.63%
Current Ratio	3.18
Quick Ratio	3.18
Altman-Z	3.02

F-Score7

WACC7.33%

ROIC/WACC0.71

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)61.15%

EPS 3Y27.76%

EPS 5Y181.5%

EPS Q2Q%504.86%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.86%

Revenue growth 3Y-3.68%

Revenue growth 5Y2.37%

Sales Q2Q%-10.1%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-17.66%

EBIT growth 3Y4.03%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-71.81%

FCF growth 3YN/A

FCF growth 5Y-21.09%

OCF growth 1Y43.49%

OCF growth 3Y55.79%

OCF growth 5Y-20.58%

HEALTH ITALIA SPA (HI.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens